ESPTX | MDIHX | ESPTX / MDIHX | |
Total Expense Ratio | 0.25 | 1.08 | 23% |
Annual Report Gross Expense Ratio | 1.22 | 1.09 | 112% |
Fund Existence | 5 years | 20 years | - |
Gain YTD | 19.143 | 19.561 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 25000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 161M | 43.3B | 0% |
Annual Yield % from dividends | 1.31 | 1.95 | 67% |
Returns for 1 year | 21.18 | 18.36 | 115% |
Returns for 3 years | 36.39 | 41.64 | 87% |
Returns for 5 years | N/A | 40.36 | - |
Returns for 10 years | N/A | 90.55 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LFLTX | 14.73 | 0.13 | +0.89% |
Lord Abbett Focused Large Cap Value R5 | |||
FMCEX | 37.95 | 0.22 | +0.58% |
Fidelity Advisor Stock Selec Mid Cp C | |||
THISX | 78.19 | 0.43 | +0.55% |
T. Rowe Price Health Sciences I | |||
NMUAX | 11.19 | 0.05 | +0.45% |
Neuberger Berman Multi-Cap Opp A | |||
CGRWX | 33.52 | -0.12 | -0.36% |
Invesco Comstock Select A |